A draft of the 2018 ACC Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk Reduction in Patients with Type 2 Diabetes is open for comment until July 5. The document focuses on key elements from emerging studies and provides succinct and practical guidance on the use of specific glucose-lowering compounds for reducing cardiovascular risk in patients with Type 2 diabetes and established cardiovascular disease. Access the document and public comment response form here.